1.ApplicationNumber: US-2407823D-A
1.PublishNumber: US-2407823-A
2.Date Publish: 19460917
3.Inventor:
4.Inventor Harmonized:
5.Country: US
6.Claims:

7.Description:
(en)Patented Sept. 17, 1946 ANTIHEMORRHAGIC E STERS AND METHODS 1 FOR PRODUCING THE SAME 1 Louis F. Fieser, Belmont, Mass., assignor to Research Corporation, New York, N. Y., a corporation of New York No'Drawing. Application December 23, Serial No. 310,855 1 20 Claims. (01. 260-457) The invention herein described relates to certam new ester derivatives of antihermorrhagic principles having the distinctive property of being readily soluble inwater, and to methods of producing these derivatives.
Among these substances, for instance, are the sulfuric .and phosphoric acid derivatives of the hydroquinones corresponding to vitamin K1, 2- methyl-1,4-naphthoquinone, and 2,3-dimethyl- 1,4-naphthoquinone; the salts of these sulfuric and phosphoric acid derivatives also come within the scope of my invention.
Vitamin K1 the antihemorrhagic factor of alfalfa which can be isolated readily from this sourceby a process previously described (application 294,318 issued as Pat. No. 2,357,944 on Sept.- 12, 1944), has been shown to be identical with 2 -mthyl-3-phytyl-L4-naphthoquinone, a
substance easily obtainable by synthesis (application 294,317). V
The vitamin is fat-soluble, but it does not dissolve to any appreciable extent in water, and the usual method of administration consists in giving the material by mouth together with sufficient bile salts to insure its absorption by the system. Aqueous dispersions, suitable for the intravenous injection of the material, can be made only by using a large volume of solvent, and no true aqueous solution can be obtained, The same is true of simpler quinones having antihemorrhagic activity, such as the substancesidescribed in a previous application (application 282,427 issued as Pat. No. 2,352,528 on June 27, 1944), including Z-methyl-1,4-naphthoquinone and 2,3-dimethyl- 1,4 naphthoquinone. In therapeutic practice it isoften highly desirable to administer a vitamin K principle in a small volume of a true aqueous solution and my invention provides a means for accomplishing this objective.
Suitable methods for producing 2-methyl-3- phytyl-1,4-naphthohydroquinone have been described (application 294,318), and the substance will hereafter be referred to as vitamin K1 hydroquinone and ascribed the formula I. When this substance is treated in pyridine solution with chlorosulfonic acid it is converted into the OH OSOaM disulfuric acid derivative (II,M=H) By suitable neutralization this derivative can be converted into various salts, such as the crystalline dipotassium salt. In an analogous manner, interaction of I with phosphorus oxychloride affords the diphosphoric acid III(M =H) which can be isolated as such in the form of a nearly colorless Motion" (Phytyl) amorphous solid. The substance dissolves readily in water and is precipitated by the addition of hydrochloric acid, even from a solutionof the sodium or potassium salt. V
In the same way, Z-inethyl-IA-naphthdhydroquinone and 2,3-dimethyl-1,4-naphthohydroquinone can be converted into the corresponding sulfuric acid and phosphoric acid derivatives and their salts; and indeed the process is entirely general and applies to the production of a wide variety of acidic ester derivatives of the reduced K2 occurring naturally in various foodstufis, the
new derivatives dissolve readily in water, rather than in lipoids, and are entirely suitable for administration in a small volume-of an aqueous solution. Furthermore, when assayed by the usual procedure in vitamin K-deficient chicks, many of the new Water-soluble substances show marked antihemorrhagic activity and compare in potency with the lipoid-soluble vitamin K1 and with 2-methyl-1,4-naphthoquinone.
Whether the esters are antihemorrhagic as such or undergo hydrolysis and oxidation in the organism cannot as yet be stated, but for practicalpurposes of medicine the new substances provide the means for a distinct advancement of vitamin K therapy. While vitamin K1 heretofore has been given either by mouth with ox bile to aid in its absorption, or by intravenous injection in a very large volume of a dispersion in glucose solution, the new vitamin K1 hydroquinone diphosphoric acid is suitable for administration in a small volume of water or buffer salt solution. Even when given by mouth, the substance promptly reduces the blood clotting time of K-deficient chicks, and it can be properly described as a "Water-soluble form of vitamin 3 It is noteworthy that the derivative, unlike the natural vitamin, is a solid and not a liquid, that it does not absorb light in the visible region of the spectrum, and thatit isc more stable both as such and in solution' than the vitamin and can be stored more successfully.
Certain other antihemorrhagic substances have.
been suggested for use in parenteral therapy but the new substances herein described. are of a quite different type and possess certain distinct" Almquist and Klose (J. Am. Chem..
advantages.
' holic alkali (naphthotocopherol?).
4 mixture with a stirring rod and heating to the boiling point for min. the reaction product separates as a viscous mass. After cooling and diluting with ether, the material is obtained as a stickysolid which is collected and-washed with etheri The' motherliquors" and washings afford 0.17 g. of oil which gives no color test with alco- The collected 'solidjprobably thepyridine salt) is treated slow- $00., 61, 1923" (1939)) suggestedthe use of phthiocol in the form of theso'l'u'ble'sodium salt, but the substance suffers from being only feebly active as compared with vitamin K1. Doisy, et al. (J. Am. Chem. Soc., 61, 1932, 2563 (1939)) proposed the use of certain naphthohydroquinone and aminonaphthol derivatives in aqueous solu-' tions of their salts, but the extreme sensitivity of these substances to air oxidation imposes a se rious limitation on their use. The new esters embodied in the present discovery differ in that they" are not subject to such oxidation, the'phenolic hydrogens being replaced by acidic residues of-adequate stability;
That the biological activity of vitamin K1 and other quinonoid substancesin'certain cases would be retained on conversion tothe sulfuric or phosphoric acid esters of the 'hydroquinones was not predictable. of its biological potencyfonconversion to the water-soluble oestrone sulfate (Butenandt and Hofste-tter, Z. physiol. "Chem; 259, 222 (1939)). Indeed vitamin K1 hydroquinone disulfate shows no activity in the chick, assays when administerefd' at: 'a" level"of"50 0B; The dipho'sphoric acid derivative, howeverygivesa' positive response at 25 Tand therefore does not fall' very far short of the potency of the naturalvitafrnin. The nature of the acidradical is thus'ofj importance, but the result" may depend" as' well upon the character of thenuclear part'of the molecule;
Particularly potent fis'sodium 2-methy1-'-1,4-'
naphthohydroquinone disulfate, which showsa'c-' T345 tivity when assayed. at dosages down to and ineluding 26;" This substance; 'ffurtherm'ore; has given successful clinicalresults'; promptly recluc- Thus oestrone loses practically allfor 2fhrs.-gave the following-analysis. f
ing the 'prothrombin' clottingtimewhen' given intravenously, for example, using 10 mg. of salt dissolved in10 "cc, of physiological saline solution, autoclaved'at 250 F.
The following procedures illustrate methods suitable for the preparation ofa numberof wa ter soluble derivatives of the gene'ral'nature em-' bodied'in my'invention and they exemplifya type of reaction and atype of compound which can be extended in many directions; 'Thus' a great" many similar water-soluble'esters may be pro duced' by the application of the fundamental principle of the interaction of a quinone of the naphthalene or other series, in its reduced form; with the halide of an acid such as sulfuric or phosphoric acid. The following examples provide a, few illustra= tions ofthe application of the fundamental discovery. I
- EXAMPLES (l)- Potassium vitamin K1 hydroquz'none -disulfate.To a mixture of 2 cc. of pyridine i and 5 cc." of carbon tetrachloride 0:6 cc. ofchlorosu-lfonic acid is slowly addedand the resulting hotsuspension containing separated" salt -is cooledto room temperature and treated with 0.48 gi 'of vitamin K1 hydroquinone. On manipulating the ly'while cooling with sufficient 10 N sodium hydroxide to just produce a red color, indicating that anfexcess of alkali is present. The oily mixture isstirrediwithia portion of ether to dissolve the pyridine, and the sodium disulfate ester is .separated from the liquor by .centrifugation and obtained as a dark oil, which becomes waxy on Anal- Ca led for oamfiosszKz-o; 54.04 gavef K; 11.35. Found-1 c, 5 J H if; K, 10. 7. p
(2) Sodium 2 math phmet aip m none disulfate A--"cool ,dc suspension" from l fcc. of pyridine, v .*of carbon tetrachloride and-0 5 cc." of"chloro sulfon-ic'acidistreated with 0:5 2-methyl-lA-naphthohydroquinone andrthe ture'heated-for 10 min. on the steambath; gi a yellow oil. The solvent is decanted after coo ing and the'oil neutralized'with 10% sodium lilydroxide, using a slightexcess ,to insureydeconiposition of any-chlorosul-fonic acid and liberation of pyridinek The mixture isthenfextracted thor-" oughly with ether and the residual re d oil taken" up:-inaftaw cc: of hot waten; Alcoholis-then' ,added'inportions, :the first of which precipitate s a smalr amount 'of" inorganic material, "wli is? removed. 5 Furtheraddition' of alcohol giv i g. of tan, crystalline precipitate of the sod um salt; and 0. 27 g. 'r'nore is obtainedfon{evaporating the mother liquor. rystallization Grete -erase;
salt-fromwater givesfiQA' g. of colorless productfree from inorganic salts, and'this isjfurther purlfied by dissolving it in water andf-adding' falcoholj The air dried material provedtobea di-hydi- An-al. Calcd. for C11HsQ8S2N2gL2H2OQ -31 H, 2.92; Na,1-1.1 0; H20, 8.7-0; Found; o;
3) sodium as-dime h' zugr apmh gam qu none disulfate.The cooled 'susp'ensiofn ofthe addition productfr'om- 055 cc; ofchlorosulfonic acid,-1-cc. ef'pyridine and- 10 cc. 'of-carbontet a chlorideis treated with 0.5 g. of Z jB dimethyF-IAE naphthohydroquinone and the mixture heated for 15 min. on the steambath, givinga pink o'i'lwhich solidifies on cooling; The solid is fcollect ed and washed rapidly, asit" isquitehygioscopic, and it is at oncetreated with a little water and neutralized with 10 N. sodium hydroxide. The residue remaining after digestion with ether is crystallized once from water (0.8g) and further purified by dissolvingit in water and adding alcohol. The sodium salt is thus obtained as colorless plates. Drying in vacuum at resulted in some darkening, and analyses were conducted 1 on air-dried material, which appears to be the h te V J11. I. ii
. AnaL Calcd. for C1'2I-I1dOsSzNazI2Ha05 C; 33.64; H, 3.29; Na, 10.74; H20, 8541-1 Found:"C, 33.47; H, 3.49; Na,'10.97; E20, 9.00. I I (4) Sodium- -2-methyl Ld nqphtltohydroquinone 'driphosphate (normal tetra-sodium salt A solution of 0.3 of 2'-methyl-1-',1-naphthohydroquinone in 0.8 cc. of pyridine is added by drops with ice coolin to a suspension prepared byadding 0.5 cc. of phosphorus oxychlorid with ice cooling to 1 cc. of pyridine. At the end the 'mitxure is removed from the ice bath and allowed to warm up untiltheexothermic reaction is over. The white suspension is then treated with (ice. of watenadded cautiously at first with icecoolingand later heating todissolve the prodllct. 'Solidgsodium' carbonate is added "until alkalineto litmus and the-pyridine layer whichseparates'is removed and discarded. The solution of sodium salts .is stirred with an equal volume of absolute alcohol and the solvent decanted, leaving an aqueoussolution of greatly diminished volume. .Thelremainder otthe water can be removedby stirring f either with fresh-portions of absolute alcohol or with two small portions of pyridine, the dehydrating solvent being decanted from the gummy sodium salt. Inorganic salts can be largely eliminated by dissolving the gum in the least amount of hot water, cooling in ice, centrifuging and decanting from the crystallizate. Alternately, the gum is treated in the cold with methanol and enough water to bring the oily salt into solution; by adjusting the proportions of solvents inorganic salts are left undissolved and are removed by filtration. For crystallization of the product such a methanol-water filtrate is concentrated and cooled, oily salt is brought into solution with a little water, pyridine is added by drops until the solution becomes cloudy, and On warming on the steam bath the sodium diphosphate separates as an oil which then crystallizes (the salt isless soluble hot than cold). The colorless crystals are collected, washed with methanol, and air dried; yield 0.68 g. The substance is Very hydroscopic and liquefies on exposure to moist air, The sample for analysis was dried at 150 and 2 mm.
Anal. C'alcd. fOl C11HaOsP2Na4.2I-I2O: C, 28.83; H, 2.64. Found: C. 28.36; H, 2.21.
The potassium salt does not crystallize readily; the calcium salt is precipitated from a dilute aqueous solution of the sodium salt in a gelatinous condition.
(5) Vitamin K1 hydroquinone diphosphoric acid.A solution of 0.48 g. of vitamin K1 hydroquinone in cc. of pyridine is cooled to 2 and added to a similarly cooled solution of 1 cc. of phosphorus oxychloride in 5 cc. of pyridine. The temperature rises to about and pyridine hydrochloride crystallizes. The solvent is largely removed in vacuum at a temperature not above 45 and the residue is treated with 10 cc. of water and extracted with ether. The ethereal extract is then shaken with a slight excess of 1 N sodium hydroxide and the alkaline layer is separated and acidified with hydrochloric acid. The diphosphoric acid thereby precipitated is extracted with ether and obtained by complete evaporation of the solvent as a light tan amorphous solid (0.4 g.). The process of purification is repeated, the solid being dissolved in 1 N sodium hydroxide, the solution extracted with ether, separated and acidified. The precipitated material is taken up in ether and the solvent is evaporated, giving a somewhat waxy, nearly colorless solid. The substance forms a gel when treated with just a small amount of water but dissolvestb a clear solution when an adequate quantity of water is used. The sample for analysis was dried at and 1 mm.
Anal. Calcd. for C31H5008P2: C, 60.76, H, 8.23. Found: C, 60.92; H, 8.20.
These examples are given to illustrate the nature of the invention but not by way of limitation. Obviously many modifications can be made in the nature of the. phenolic and the acid halide components and in the proportions of reagents and details of the condensation and isolation procedures without departing from the essential spirit and scope of the disclosures herein presented.
I claim:
1. Process for the production of water soluble ester derivatives of -1,4-naphthohydroquinones which comprises condensing a 1,4-nap hthohydroquinone of the general formula 5. Process as defined in claim 1 in which the halide of a polybasic mineral acid is phosphorus oxychloride.
6. A compound of the formula:
thereof.
7. A compound of the formula:
(iXP O 3M CHa C20Hu POsM:
where M is selected from the group consisting of hydrogen and alkali metal.
8. The compound of the formula:
CzuHan POzHI 7 w 9: Y "A'eompoundof the fo'rmul'az V I l 11. Compounds as defined in claim 6 in which v20 R stands for hydrogen.
12. Compounds as defined in claim 6 in which R stands for a phytyl group.
13. A compound selected from the group consisting of the'di-sulphate ester of 2-methyl- 1, 4- naphthohydroquinone; and the. water-soluble salts thereof.
14. A compoundselectedfrom the group consisting of the di-phosphate ester of 2-methy1-1, 4-naphthohydroquinone, and the water-soluble salts thereof.
15. 2-methyl-L4-dihydroxy naphthalene disulfate.
16. The method of preparing a sulfuric acid ester of 2 methyl-1,4-naphthohydroquinone which comprises reacting 2-methy1-1,4'-naphtho ,hydroquinone with chlorosulfonic acid.
1'7. The method of preparing a phosphoric acid ester of 2 methyl -'1,4-naphthohydroquinone which comprises reacting Z-methyI-IA-naphthO- hydroquinone with phosphorus oxychloride.
18. A di -phosphate ester of 2-methy1-1,4- naphthohydroquinone.
19. A water-soluble salt of adi-phosphate ester of 2-methyl-1,4r-naphthohydroquinone.
20. A water soluble salt of the disulfuric acid 7 ester of Z-methyl-1,4-naphthohydroquinone.
LOUIS F. FIESER.